1 – 10 of 17
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2018
-
Mark
Accuracy of self-reported family history of cancer, mutation status and tumor characteristics in patients with early onset breast cancer
(
- Contribution to journal › Article
- 2016
-
Mark
Cancer in first-degree relatives of women with early-onset breast cancer: a comparison of self-reported and cancer registry data
(
- Contribution to journal › Published meeting abstract
- 2015
-
Mark
Increasing age at first full-time pregnancy correlates to use of oral contraceptives before age 20 in women with a family history of breast cancer
2015) 106th Annual Meeting of the American Association for Cancer Research(
- Contribution to conference › Abstract
- 2014
-
Mark
Long-term prognosis of early-onset breast cancer in a population-based cohort with a known BRCA1/2 mutation status.
(
- Contribution to journal › Article
-
Mark
High risk of in-breast tumor recurrence after BRCA1/2-associated breast cancer.
(
- Contribution to journal › Article
- 2012
-
Mark
Ovarian cancer susceptibility alleles and risk of ovarian cancer in BRCA1 and BRCA2 mutation carriers
(
- Contribution to journal › Article
- 2010
-
Mark
Association of the Variants CASP8 D302H and CASP10 V410I with Breast and Ovarian Cancer Risk in BRCA1 and BRCA2 Mutation Carriers.
2010) In Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 19. p.2859-2868(
- Contribution to journal › Article
- 2004
-
Mark
One in 10 ovarian cancer patients carry germ line BRCA1 or BRCA2 mutations : results of a prospective study in Southern Sweden
(
- Contribution to journal › Article
- 2000
-
Mark
Risk perception, screening practice and interest in genetic testing among unaffected men in families with hereditary prostate cancer
(
- Contribution to journal › Article
- 1999
-
Mark
Incidence of malignant tumours in relatives of BRCA1 and BRCA2 germline mutation carriers
(
- Contribution to journal › Article